NALCN,

Xuewei Li1,2, Na Wu3, Chen Wang3

  • 1Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Shanxi Medical University, Taiyuan, China.

Frontiers in immunology
|February 27, 2025
PubMed
概括

一种瘤抑制剂NALCN在胃癌 (GC) 中降低调节,影响免疫细胞透. 下NALCN与增加的B细胞和CD8+T细胞相关,表明其作为GC中的免疫生物标志物的潜力.